Literature DB >> 9811515

International standardization of gene amplification technology.

J S Robertson1.   

Abstract

The WHO international Working Group on the standardization of Gene Amplification Techniques for the Virological Safety Testing of Blood and Blood Products (SoGAT) was established in 1995 as a technical discussion group. It is the only international forum for the exchange of information on scientific aspects of the technology, evaluation of the technology for the testing of products and the organisation of international collaborative studies for the development, evaluation and provision of reference materials and working standards. Materials suitable as working reagents in hepatitis C virus (HCV) gene amplification are in widespread use and plans for a collaborative study for the establishment on an HCV RNA International Standard are well underway as are studies aimed at standardizing the technology for other viruses. Copyright 1998 The International Association of Biological Standardization

Entities:  

Mesh:

Year:  1998        PMID: 9811515     DOI: 10.1006/biol.1998.0136

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  6 in total

1.  Purification and characterization of PCR-inhibitory components in blood cells.

Authors:  W A Al-Soud; P Rådström
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 2.  Molecular monitoring of BCR-ABL transcripts in patients with chronic myelogenous leukemia: is high sensitivity of clinical value?

Authors:  Maxim Norkin; Charles A Schiffer
Journal:  Curr Hematol Malig Rep       Date:  2010-04       Impact factor: 3.952

3.  Standardization of Diagnostics in Blood Safety.

Authors:  Jens Dreier; Holger Hennig
Journal:  Transfus Med Hemother       Date:  2015-07-20       Impact factor: 3.747

4.  Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virus.

Authors:  R T Hayden; K M Hokanson; S B Pounds; M J Bankowski; S W Belzer; J Carr; D Diorio; M S Forman; Y Joshi; D Hillyard; R L Hodinka; M N Nikiforova; C A Romain; J Stevenson; A Valsamakis; H H Balfour
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

5.  First external quality assurance program for bloodstream Real-Time PCR monitoring of treatment response in clinical trials of Chagas disease.

Authors:  Juan C Ramírez; Rudy Parrado; Elena Sulleiro; Anabelle de la Barra; Marcelo Rodríguez; Sandro Villarroel; Lucía Irazu; Cristina Alonso-Vega; Fabiana Alves; María A Curto; Lineth García; Lourdes Ortiz; Faustino Torrico; Joaquim Gascón; Laurence Flevaud; Israel Molina; Isabela Ribeiro; Alejandro G Schijman
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

Review 6.  Ensuring the biologic safety of plasma-derived therapeutic proteins: detection, inactivation, and removal of pathogens.

Authors:  Kang Cai; Todd M Gierman; JoAnn Hotta; Christopher J Stenland; Douglas C Lee; Dominique Y Pifat; Steve R Petteway
Journal:  BioDrugs       Date:  2005       Impact factor: 5.807

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.